Tricuspid Regurgitation clinical trials at University of California Health

• A Study to Evaluate an Experimental Tricuspid Valve Repair System (TRILUMINATE Study)

  open to eligible people ages 18 years and up

  The primary objective of this trial is to demonstrate the safety and effectiveness of the TriClip device in improving clinical outcomes in symptomatic patients with severe tricuspid regurgitation (TR), who are at intermediate or greater estimated risk for mortality or morbidity with tricuspid valve surgery. This randomized controlled trial will compare the investigational device (TriClip device) to Control (Medical Therapy).

  at UC Davis

• Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

  open to eligible people ages 18 years and up

  To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team

  at UCLA

Last updated: October 6, 2021